The effects and mechanisms of acupuncture for post-stroke cognitive impairment: progress and prospects

Post-stroke cognitive impairment (PSCI) represents a growing challenge in modern medicine. Stroke is one of the leading causes of death and disability worldwide, and is particularly common in older adults. When a patient survives a stroke, they often face consequences that go beyond visible motor problems. PSCI is one such complication, characterized by difficulties with memory, concentration, reasoning, and other mental functions that may persist for months or years after the initial cerebrovascular event.

This condition affects approximately half of stroke survivors within the first year, becoming the leading cause of long-term disability and significant reduction in quality of life for these patients. The impact is not limited to the individual but extends to families and the healthcare system as a whole, representing a considerable economic and social burden.

This comprehensive study analyzed 25 years of scientific research on the use of acupuncture in the treatment of PSCI, examining both clinical studies in patients and experiments in laboratory animals. The investigators conducted a systematic review of the scientific literature, selecting articles published between 1998 and 2023 in major medical databases. After rigorous inclusion and exclusion criteria, 38 basic experimental studies and 22 clinical studies were analyzed, investigating different modalities of acupuncture, including manual acupuncture, electroacupuncture, and transcutaneous electrical stimulation at acupuncture points. The primary objective was to understand how acupuncture may benefit patients with PSCI and to identify the biological mechanisms behind these therapeutic effects.

The methodology included a detailed analysis of the types of experimental models used, the acupuncture points selected, the treatment parameters applied, and both behavioral and biochemical outcome measures.

The results revealed compelling evidence that acupuncture may exert significant beneficial effects on PSCI through multiple neuroprotective mechanisms. First, the technique demonstrated the ability to prevent programmed cell death (apoptosis) of neurons, a destructive process that contributes to worsening brain damage after stroke. Acupuncture can regulate important proteins that control cell survival, such as increasing the expression of the Bcl-2 protein (which protects cells) and decreasing the expression of the Bax protein (which promotes cell death). Second, the studies showed that acupuncture promotes synaptic plasticity, that is, the brain's ability to form new connections between neurons and strengthen existing ones.

This is fundamental for the recovery of cognitive function, as it allows healthy areas of the brain to compensate for areas damaged by the stroke. Third, acupuncture demonstrated potent anti-inflammatory action, reducing inflammation both in the central nervous system and throughout the rest of the body. Chronic inflammation is a factor that perpetuates brain damage after stroke, and its reduction is crucial for recovery. Finally, the technique showed the ability to regulate cerebral energy metabolism, improving blood flow in the brain, glucose utilization by neurons, and mitochondrial function (the cells' "energy powerhouses").

From a clinical standpoint, these findings have important implications for both patients and healthcare professionals. For patients with PSCI, acupuncture emerges as a promising and safe complementary therapeutic option that can be used alongside conventional treatments. The clinical studies included in the review demonstrated significant improvements on standardized cognitive assessment scales, such as the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), as well as benefits in activities of daily living and reduction of associated symptoms such as anxiety and depression. Scalp acupuncture proved particularly effective, likely due to its proximity to the affected brain areas.

Specific points such as Baihui (top of the head) and Zusanli (below the knee) were consistently effective across studies. For healthcare professionals, these results provide scientific support for considering acupuncture as part of an integrated treatment plan for patients with PSCI. The World Health Organization already recognizes acupuncture as a valid complementary strategy for stroke care, and these findings reinforce its specific applicability to the cognitive consequences.

It is important to acknowledge several significant limitations of this research that should guide future interpretations. First, the methodological quality of the clinical studies varied considerably, with many having small samples, inadequate controls, and insufficient follow-up periods. Second, the heterogeneity of acupuncture protocols used across the different studies makes it difficult to standardize specific therapeutic recommendations. Third, most mechanistic studies were performed in animal models, and the translation of these findings to humans requires caution.

In addition, many studies did not include true placebo control groups, which is particularly challenging in acupuncture research. Going forward, high-quality randomized clinical trials are needed, with double-blind methodology when possible, larger samples, multiple research centers, and long-term follow-up. It would also be valuable to develop standardized acupuncture protocols specifically for PSCI, taking into account the treatment individualization that is characteristic of Chinese medicine. Despite these limitations, the results of this comprehensive review provide solid scientific evidence that acupuncture represents a multifaceted, neuroprotective therapeutic approach with real potential to improve the quality of life of patients with post-stroke cognitive impairment.